{"id":51276,"date":"2026-03-24T12:08:09","date_gmt":"2026-03-24T11:08:09","guid":{"rendered":"https:\/\/www.bricbordeaux.com\/2026\/03\/new-article-from-the-mircade-team-a-promising-breakthrough-in-the-fight-against-hepatoblastoma\/"},"modified":"2026-03-24T16:26:03","modified_gmt":"2026-03-24T15:26:03","slug":"new-article-from-the-mircade-team-a-promising-breakthrough-in-the-fight-against-hepatoblastoma","status":"publish","type":"post","link":"https:\/\/www.bricbordeaux.com\/en\/2026\/03\/new-article-from-the-mircade-team-a-promising-breakthrough-in-the-fight-against-hepatoblastoma\/","title":{"rendered":"New article from the MIRCADE team. A promising breakthrough in the fight against hepatoblastoma"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong>A promising breakthrough in the fight against hepatoblastoma<\/strong><\/h2>\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.bricbordeaux.com\/bric-team\/mircade-methodes-et-innovations-pour-la-recherche-sur-les-cancers-de-lenfant\/\" type=\"bric-team\" id=\"17338\">Team 6 MIRCADE<\/a> (Methods and Innovations for Research on Childhood Cancers), led by<a href=\"https:\/\/www.bricbordeaux.com\/people\/christophe-grosset\/\" type=\"people\" id=\"17502\">Dr. Christophe Grosset<\/a> , a Research Director at Inserm, has just published a significant article in the prestigious journal <em>Molecular Cancer<\/em>, shedding new light on hepatoblastoma, the most common form of liver cancer in children. This work is part of a translational research initiative aimed at identifying new therapeutic solutions and accelerating their transition to clinical practice.<\/p>\n\n<p class=\"wp-block-paragraph\">Hepatoblastoma is a rare liver tumor that primarily affects children under the age of five. While current treatment strategies, which combine chemotherapy and surgery, generally yield good results, aggressive or chemotherapy-resistant forms of this cancer continue to be associated with a poor prognosis, underscoring the need to develop new targeted approaches.<\/p>\n\n<p class=\"wp-block-paragraph\">In this study, researchers demonstrated that the EZH2 protein promotes the development of hepatoblastoma, particularly the most aggressive tumors. They then targeted the EZH2 protein with a specific inhibitor, GSK126, and found that the treatment-resistant cells produced significant amounts of lipids. By combining GSK126 with a statin, they were able to effectively destroy cancer cells and block tumor growth in an animal model. Typically prescribed to lower cholesterol, statins are the subject of extensive research in oncology, and their use in combination with other treatments appears very promising for many types of cancer.<\/p>\n\n<p class=\"wp-block-paragraph\">These results demonstrate the potential of repurposing existing drugs as a rapid and effective way to provide new treatment options for children with cancer, particularly those with resistant and aggressive forms of the disease.<\/p>\n\n<p class=\"wp-block-paragraph\">These studies, published in a leading scientific journal, attest to the high quality of the research conducted by our teams at the Bordeaux Institute of Oncology and their dynamism, and demonstrate our commitment to developing innovative approaches in pediatric oncology.<\/p>\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"tb-button\" data-toolset-blocks-button=\"1a28d8cdeece039799e9a10cb46e1c5a\"><a class=\"tb-button__link\" href=\"https:\/\/presse.inserm.fr\/une-nouvelle-piste-therapeutique-contre-lhepatoblastome-principal-cancer-du-foie-chez-lenfant\/72352\/\"><i class=\"tb-button__icon\"><\/i><span class=\"tb-button__content\">Inserm Press Release<\/span><\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"tb-button\" data-toolset-blocks-button=\"3196031dd6313384b74b2987936a7890\"><a class=\"tb-button__link\" href=\"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02474-9\"><i class=\"tb-button__icon\"><\/i><span class=\"tb-button__content\">Article published in <em>Molecular Cancer<\/em><\/span><\/a><\/div>\n<\/div>\n<\/div>\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.bricbordeaux.com\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-1024x576.jpg\" alt=\"\" class=\"wp-image-51272\" srcset=\"https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-1024x576.jpg 1024w, https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-300x169.jpg 300w, https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-768x432.jpg 768w, https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-1536x864.jpg 1536w, https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-700x394.jpg 700w, https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031-539x303.jpg 539w, https:\/\/cdn-bricbordeaux.onlc.eu\/wp-content\/uploads\/2026\/03\/article-mol-cancer-team-6-2026-031.jpg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<p class=\"wp-block-paragraph\">Thanks to our funders!<\/p>\n\n<p class=\"wp-block-paragraph\">Groupama Centre-Atlantique<br\/>La R\u00e9gion Nouvelle-Aquitaine<br\/>La Fondation Groupama pour la Sant\u00e9<br\/>l\u2019Institut National du Cancer (INCa)<br\/>La Fondation Bergoni\u00e9<br\/>the Foundation for Addies\u2019s Research,<br\/>La Ligue Nationale contre le Cancer<br\/>Instituto de Salud Carlos III<br\/>European Union&#8217;s Horizon 2020 research and innovation program<br\/>Catalan Agency for Management of University and Research Grants<br\/>the Ram\u00f3n y Cajal program of the Spanish Ministry of Science and Innovation<br\/>Imagine for Margo<br\/>Foundation KickCancer<br\/>Aidons Marina<br\/>E.S.CA.P.E.<br\/>Eva pour la Vie<br\/>Les R\u00e9coltes de l\u2019Espoir<br\/>Pour Emma<br\/>Scott &amp; Co<br\/>CIBERehd<br\/>AGAUR<br\/>the Scientific Foundation of the Spanish Association Against Cancer<br\/>Fight Kids Cancer Funding Program<br\/>Foundation Kriibskrank Kanner and Federazione italiana Associazioni Genitori e Guariti Oncoematologia Pediatrica<br\/>Cris Cancer Foundation<br\/>the Agency for Management of University and Research Grants<br\/>Cassandra<br\/>Nathana\u00ebl du R\u00eave et de l\u2019Espoir<br\/>No\u00ebline ma Fille ma Bataille<br\/>Sph\u00e8res<br\/>Warrior Enguerrand<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A promising breakthrough in the fight against hepatoblastoma Team 6 MIRCADE (Methods and Innovations for Research on Childhood Cancers), led byDr. Christophe Grosset , a Research Director at Inserm, has just published a significant article in the prestigious journal Molecular Cancer, shedding new light on&#8230;<\/p>\n","protected":false},"author":3,"featured_media":51273,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[111,8],"tags":[],"class_list":["post-51276","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts\/51276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/comments?post=51276"}],"version-history":[{"count":2,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts\/51276\/revisions"}],"predecessor-version":[{"id":51278,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts\/51276\/revisions\/51278"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/media\/51273"}],"wp:attachment":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/media?parent=51276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/categories?post=51276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/tags?post=51276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}